Dernières nouvelles pour IM Cannabis (NASDAQ:IMCC) Stock

IM Cannabis

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

IM Cannabis Corp

Earnings

Press Releases

IM Cannabis Reports Third Quarter Financial Results

Small Cap

IM Cannabis Announces Change of Auditors

IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET

IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results

IM Cannabis Provides Corporate Updates

IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET

IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction

IM Cannabis Reports First Quarter Financial Results

IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange

CSE:IMCC

IMCC

Comments

IM Cannabis

Actualités

Dernières nouvelles pour IM Cannabis (NASDAQ:IMCC) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL